INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 21, 2017 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 176,223 | -- | 323,777 |
| Jul 21, 2017 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 176,223 | -- | 331,629 |
| Dec 16, 2016 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 89,427 | -- | 500,000 |
| Dec 16, 2016 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 89,427 | -- | 159,324 |
| Dec 17, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 1,921 | -- | 500,000 |
| Dec 17, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 1,921 | -- | 569,897 |
| Nov 02, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 43,348 | -- | 500,000 |
| Nov 02, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 43,348 | -- | 612,936 |
| Dec 19, 2016 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,676 |
| Dec 16, 2016 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 146,815 | -- | 146,815 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.